Meccellis Biotech manufactures medical devices (CELLIS®) made of biologic tissues from animal origin. Its proprietary manufacturing process allows to « clean » porcine materials from all cells and pathogens. It results in a biocompatible matrix which incorporates into the host tissue enabling replacement of anatomic portions losses (complex abdominal surgeries, breast reconstructions…).

Funding: In process of first Serie B in Europe (new manufacturing plan for XENOPHA® – closing 2021) / Looking for Serie B in 2023 for US market